Alternatives to Verismo Therapeutics, .
Verismo Therapeutics, . is a Biotech tool: developing a novel KIR-based CAR T-cell therapy to overcome T-cell exhaustion and target solid tumors. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Verismo Therapeutics, .
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Tharimmune53BiotechCambridge, United States$540.0MBiotechnology company developing novel immunotherapies for cancer.
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
- Website
Leap Therapeutics50BiotechCambridge, United States$189.0MLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
- Website
MacroGenics49BiotechRockville, United States$13.5MBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
- Website
C4 Therapeutics49BiotechBoston, United States$371.0MBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
- Website LELeman Biotech48BiotechShenzhen, China$22.7M
Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website ALAlpha9 Theranostics44BiotechVancouver, Canada$10.0M
Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.
- Website
32 Biosciences42BiotechSan Diego, United States$12.0MDevelops novel therapeutic antibodies for oncology and autoimmune diseases.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
CureVac40BiotechTübingen, Germany$2.1BBiopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Sutro Biopharma40BiotechSouth San Francisco, United States$296.4MClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
Showing the 20 closest matches. See the rest on the Verismo Therapeutics, . profile.
Compare Verismo Therapeutics, . head to head
Side by side on what each one does, what it costs, and what real users report.